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Environmental and health risks of nanorobots: an
early review
Rickard Arvidsson *a and Steffen Foss Hansen b
Nanorobots for biomedical applications have experienced extensive research and rapid development
during the last decade, up to a point where they can now deliver cargos to designated sites in organisms
under laboratory conditions. Despite this development, research into nanorobot risks and discussions about
potential regulation of nanorobots have so far been limited. This early review of risks related to nanorobots
first provides a brief overview of the current state of the technology. The overview outlines three main
types of nanorobots: helices, nanorods and DNA nanorobots. Several different designs exist for each of
these categories. Second, early indications of potential hazards are reviewed and discussed. Two potential
hazards are highlighted: (i) the use of hazardous materials and UV light in nanorobots, and (ii) the loss of
propulsion/targeting control. Third, how current regulations are adapted to nanorobots is discussed.
Current regulations for medical devices are clearly not adapted to nanorobots and it is even unclear which
specific regulations might be applicable. In order to make the most of the use of nanorobots, we
recommend they should be subject to broad, risk-related studies as well as dialogues with stakeholders
and the public about the definition, purpose and controllability of nanorobot applications. A list of ten
priority questions to be addressed in future risk-related studies of nanorobots is provided.
1. Introduction
In a foundational paper, Roco1 distinguished between a
number of generations of nanotechnology, the two earliest
being passive and active nanostructures. Tour2 used a similar
categorization and defined passive nanotechnology as when
“the nano part does nothing particularly elaborate”. Active
nanotechnology was defined as when “the nano entity does
something elaborate such as absorbing a photon and releasing
an electron, thereby driving a device, or moving in a specific
and definable fashion across a surface”. Although the exact
distinction between the passive and active nanotechnology can
be tricky, conventional nanoparticles and nanotubes currently
used in existing nanoproducts3,4 generally belong to the
category of passive nanomaterials. This is where most efforts in
terms of risk-related research have occurred during the 2000s,
in particular for a limited set of nanomaterials, including silver
nanoparticles, titanium dioxide nanoparticles, silica
nanoparticles, cerium dioxide nanoparticles, zinc oxide
nanoparticles, iron nanoparticles, quantum dots, fullerenes,
carbon nanotubes and graphene.5–9 Much less attention has
been given to active nanomaterials, probably because of their
limited production and use in society. However, one type of
active nanomaterial is clearly on the march. Often referred to
as science fiction, nanorobots are currently being extensively
researched and developed, especially for medical applications
where there is an effort to merge nanotechnology with
pharmaceuticals.10,11 The most frequent application mentioned
is drug delivery, in particular for site-specific cancer treatment
through the delivery of tumor-killing drugs.12 Other envisioned
areas of applications beside medicine include environmental
monitoring and water remediation.13
Despite this development, research on risks related to
nanorobots have so far been limited. History shows several
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Environmental significance
So far, discussions and research about environmental and health risks related to nanomaterials have focused on so-called passive nanomaterials, such as
metal-oxide nanoparticles and carbon nanotubes. Much less attention has been given to so-called active nanomaterials. This includes nanorobots, which
are individual nano-sized devices able to perform designated tasks, so far given limited attention regarding their potential future risks. This paper provides
a review of early indications of potential environmental and health hazards related to nanorobots, investigates the applicability of existing regulatory
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examples of how the introduction of new technology that
offered great benefits into society later turned out to also
cause notable environmental and health impacts.14,15
Regulation was generally imposed only at a late stage, long
after the first signs of negative side effects appeared. A telling
example from medicine is ionizing radiation, discovered
around 1900, which brought important diagnostic and
therapeutic benefits through X-rays and radioisotopes.
Already at that time, there were early reports that exposure to
radiation could cause severe damage, but these were largely
overlooked. X-rays were even used for fitting shoes and
removing unwanted hair in beauty shops in the 1930s and
1940s. Such misuses were possible because of the lack of
regulation ensuring the safety of ionizing radiation. Only very
slowly have such regulations evolved as the knowledge about
radiation risks grew bigger, eventually enabling the beneficial
use of radiation while keeping risks reasonably low.16
Another important medical discovery – perhaps the most
important of all times – is antimicrobials, which have saved
millions of lives by killing malign bacteria. In parallel with
such predominantly beneficial uses, antimicrobials have also
been used as growth promotor in industrialized animal
husbandry. Animals fed with sub-therapeutic amounts of
antimicrobials for long time periods showed enhanced
properties, such as increased growth rate, food conversion,
egg production and milk yield. Much a consequence of such
extensive use, antimicrobial resistance began to be reported
as early as the 1940s, threatening the use of antimicrobials in
medicine. Bans of antimicrobials as growth promotors did
not appear until the mid 1980s.17
Considering the examples of late lessons from early
warnings for a number of previous medical technologies, it is
important to address risks of such emerging technologies at
an early stage of development, which is where we find
nanorobots today. In this paper, we present an early review of
environmental and health risks related to nanorobots. First,
we provide a brief overview of the progress in nanorobot
developments, including which types of nanorobots are
under development and in which applications they are likely
to first emerge. Second, we review existing knowledge about
nanorobots in the context of environmental and health risks,
identifying a set of potential hazards to be further studied
and scrutinized. Third, we discuss how nanorobots, if proven
risky to the environment or human health, might become
regulated. Finally, recommendations for the further enquiry
into potential risks of nanorobots are provided.
A precise definition of the term ‘nanorobot’ is currently
lacking. It is here tentatively defined as an individual nano-sized
device able to perform a designated task. The nanometer size
(referring approximately to the 1–100 nm size range) follows
naturally from the term nanorobot, while the ability to perform
tasks is central to any (also a macro-sized) robot and sets
nanorobots apart from conventional, passive nanomaterials.
This definition is similar to the one provided by Gao and
Wang13 for ‘nanomachine’: a nanoscale device that performs a
task. The main difference is that our definition specifies
individual devices themselves as being nanorobots, rather than
devices consisting of entire swarms of nano-sized robots. It
should be noted that this definition excludes a range of micro-
sized robots. A specific example is MagnetoSperm, aimed at
imitating a sperm cell in movement.18 This device has a
thickness, length and width of about 5.2, 320 and 42 μm,
respectively, which is here considered too large for a nanorobot.
Another excluded example is the artificial bacterial flagellum
described by Qiu et al.,19 which is about 1.2 μm wide and 16
μm long. Also excluded are metal–organic-framework-based
biomedical microrobots, called MOFBOTS, which are at least a
few micrometers in diameter.20 Naturally, the delimitation to
the nanoscale also excludes larger micro-sized robots, such as
the 400 × 800 μm tumbling micromotor.21 The exclusion of
such micro-sized devises in this review is done to enable a focus
on nano-sized devises, which might potentially exhibit unique
hazardous properties due to their small size.22 However, we
have been rather inclusive in our selection, including for
example robots of some hundred nanometers in at least one
dimension, even though most contemporary definitions of
nanomaterials have an upper size limit of 100 nm.23
2. Technological development of
nanorobots
The technological development of both micro- and nano-
sized robots stretches from Richard Feynman's famous talk
“There's Plenty of Room at the Bottom” in 1959 until now,
intertwined with the development of other technologies, such
as magnetic control and nanostructure synthesis.24 The first
nano-sized robots were reported in 2005, including the
nanocar made mainly by fullerene molecules.25 During the
2010s, three main designs of nanorobots have emerged:
helices (also called nanoswimmers), nanorods (also called
nanoswimmers, nanomotors or, if longer, nanowires) and
DNA nanorobots. These will be described in more detailed in
Sections 2.1–2.3 and a non-exhaustive list of nanorobot
examples is presented in Table 1. These three categories
generally fulfill the tentative definition of nanorobot in
section 1 by being both nano-sized and able to perform some
tasks. However, sometimes the task to be performed has not
yet been entirely realized for specific nanorobot designs, but
there is generally an ambition to execute successful drug
delivery or some similar task, like biological imaging. In
general, it seems that the nanorods and DNA nanorobots
have reached the furthest towards actually accomplishing
drug delivery and similar tasks.
2.1 Helices
A number of robots with screw-like helix tails for movement
have been developed, often resembling bacterial flagella or
other biological entities. Most of them are rather to be
categorized as micro-sized robots, including the above-
mentioned MagnetoSperm and the MOFBOTS. However, there



































































































Environ. Sci.: Nano, 2020, 7, 2875–2886 | 2877This journal is © The Royal Society of Chemistry 2020
nanometer size range. One example is the helical cobalt-
covered glass propeller developed by Ghosh and Fischer,26
which is 200–300 nm wide and 1–2 μm long (Fig. 1a). The
propeller is meant to mimic a bacterial flagellum in terms of
swimming behavior. Thanks to the magnetic cobalt layer, the
propeller can be moved and navigated through magnetic fields
(both backward and forward), reaching speeds of about 40 μm
s−1. The navigation control in a water-based solution is
exemplified by ‘writing’ micrometer-scale letters and symbols,
such as ‘R’, ‘@’ and ‘H’, using the propeller's trajectory. Several
propellers can be controlled simultaneously in this way.
Another helix design that might be considered a
nanorobot is the artificial bacterial flagellum by Zhang
et al.,27 which can be 200 nm thick, 2.5 μm wide and 2.5
μm long (Fig. 1b). It consists of a magnetic chromium–
nickel–gold head attached to an indium gallium arsenide–
gallium arsenide–chromium tail. It is the tail that resembles
a bacterial flagellum (both in size and shape) and the head
enables magnetic propulsion and control. The artificial
bacterial flagellum can swim at an average speed of 1.2 μm
s−1 under magnetic fields thanks to its magnetic head.
Similar to the helical glass propeller, the artificial bacterial
flagellum can move both forward, backward and turn in
water-based media depending on the shape of the helix and
the direction of the magnetic field. It was furthermore
shown that the artificial bacterial flagellum can be
controlled into pushing and rotating polystyrene
microparticles.
Table 1 Non-exhaustive list of examples of nanorobots. N.a. = not available




Helical propeller Glass, cobalt 200–300 nm
wide
Magnetism 40 26
Artificial bacterial flagellum Indium, gallium, arsenic,
chromium, nickel, gold











Drug-delivering nanorod Gold, nickel, polymer 250 nm wide Ultrasound/magnetism 50 (max) 31
Antibacterial nanorod Gold, lysozyme <300 nm wide Ultrasound/bioreceptors n.a. 32
Coated nanowire Gold, graphene oxide, DNA 200 nm wide Ultrasound/bioreceptors n.a. 33
Enzyme-bound nanowire Gold, nickel, polymer,
asparaginase
ca. 500 nm wide Ultrasound/magnetism 32 (average) 34
Light-driven nanorod Gold, iron oxide 300 nm wide Visible light/magnetism 33 37
Light-driven nanowire Silicon, platinum 500–1000 wide Visible or near-infrared
light/morphology
5–35 38
Match-like nanorod Silica, silver, silver chloride <210 nm wide UV light, silver chloride
decomposition
4–14 39
Nanorod with flagellum tail Gold, nickel, polymer 300–600 nm
wide
Acoustic waves/magnetism 60 (max) 46
V-Shaped nanorod Platinum 700 nm wide Hydrogen peroxide
decomposition
2–7 41
Nanofish Gold, nickel, silver 200 nm wide Magnetism 31 (max) 42
Two-armed nanoswimmer Gold, nickel, silver 200 nm wide Magnetism 39 (max) 43
Machine-learning optimized
nanoparticles
Polystyrene, platinum 398 nm Hydrogen peroxide
decomposition
n.a. 44




DNA walker DNA n.a. Bioreceptors n.a. 49
Molecular spiders Protein, DNA n.a. Bioreceptors n.a. 50
I-switch DNA n.a. Diffusion/bioreceptors n.a. 51
Hexagonal barrel cage DNA 35 × 35 × 45 nm Diffusion/bioreceptors n.a. 52
Tetrahedron DNA
nanoparticle
DNA 8×10 nm Diffusion/bioreceptors n.a. 53
Icosahedral DNA
nanocapsules
DNA n.a. Diffusion/bioreceptors n.a. 55
Nanosheet/tubular
nanorobot
DNA 90 × 50 × 2 nm Diffusion/bioreceptors n.a. 56
a Note that since DNA nanorobots are well-defined molecules, their size in terms of nm is not always provided. Also, their speed is not reported
to the same extent as for helices and nanorods.
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In addition to these two examples of nanorobot helices,
several similar helix-like nanorobots have been developed, where
most are micro-sized but some dwell somewhere in the
borderland between the nano- and micro-size ranges.28 There are
also attempts to use actual bacterial flagella by de-polymerizing
them into flagellin proteins using heating, then repolymerizing
them back into flagella and attaching them to magnetic particles
40–400 nm in size.29 Multiple flagella can be attached to the
same nanoparticle, but a functional group that can bind to the
nanoparticles must be introduced during the repolymerization.
The repolymerized flagella have outer diameters of about 20 nm,
lengths of 5–10 μm and can obtain different shapes (normal,
curly and coiled) depending on if ethylene glycol or dimethyl
sulfoxide is added. The idea is that reconfiguring its geometry
might be beneficial when navigating through heterogenous
biological environments (such as the human body) compared to
movement in pure water. By applying magnetic fields, the
nanoparticle–flagella clusters can swim at velocities up to 2.5 μm
s−1. An advantage of this helical nanorobot design is that the
specific nanoparticles can be changed for different purposes
while maintaining the repolymerized flagella for movement.
However, for both propulsion and navigation purposes, the
nanoparticles must be magnetic.
2.2 Nanorods
The nanorods typically consist of cylindrical rods with different
metal segments,30 although different shapes are also used for
the same purpose. A particularly notable example from a
medical point of view is the 250 nm wide and 1800 nm long
rod with gold-nickel-gold segments developed by Garcia-
Gradilla et al.31 These nanorods move due to ultrasound waves
Fig. 1 Examples of nanorobots. (a) 200–300 nm glass propeller. Reprinted (adapted) with permission from Ghosh and Fischer.26 Copyright (2009)
American Chemical Society. (b) 200 nm thick artificial bacterial flagellum made by a chromium–nickel–gold head and an indium gallium arsenide-
gallium arsenide-chromium tail. Reprinted (adapted) with permission from Zhang et al.57 Copyright (2009) American Chemical Society. (c) Gold
(Au)–nickel (Ni)–gold (Au)–polymer (PPyPSS) nanorod loaded with an antiseptic drug (brilliant green, BG). Reprinted (adapted) with permission from
Garcia-Gradilla et al.31 Copyright (2013) American Chemical Society. (d) Fish-like 200 nm wide nanorod consisting of gold–nickel–nickel–gold
segments with three flexible silver hinges linking the segments. Reprinted (adapted) with permission from Li et al.42 Copyright (2016) Wiley-VCH
Verlag GmbH & Co. (e) Hexagonal cage-like DNA robot able to transport payloads (in pink). Reprinted (adapted) with permission from Douglas
et al.52 Copyright (2012) Science. (f) DNA nanorobots consisting of 90 nm × 50 nm × 2 nm sheets able to fold into tubular drug carriers. Reprinted
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and can move in serum at about 50 μm s−1 and, albeit at lower
speed, in saliva (about 10 μm s−1). Thanks to the magnetic
properties of nickel, such nanorods can be steered along
predetermined trajectories. For example, the developers made
it ‘write’ the letters ‘U’, ‘C’, ‘S’ and ‘D’ with its trajectory. The
nanorod can be functionalized, making it carry drug cargoes.
An important potential application of the gold–nickel–gold
nanorod was shown by functionalizing it with a polypyrrole–
polystyrene sulfonate segment. This organic segment can bind
to the antiseptic drug brilliant green (Fig. 1c) and deliver this
drug to designated destinations. The drug can then become
released due to changes in pH.
Another potential medical use of nanorods was
demonstrated by Kiristi et al.32 They used ultrasound-
powered porous gold nanorods less than 300 nm wide and
functionalized them with the bactericidal substance
lysozyme, which can kill both Gram-negative and Gram-
positive bacteria. They showed that the lysozyme-
functionalized gold nanorods could kill up to about 80% of
the Gram-positive bacteria M. lysodeikticus in a sample within
a few minutes. The number of nanorods influenced the death
rate, with about 5000 being required for a rate of 80%.
Glycosidic bonds in the cell walls of bacteria act as
bioreceptors for the lysozyme. Although there was no
navigation control for this nanorobot, the movement in itself
greatly increased the lysozyme-bacteria interactions and thus
also the bacterial killing capacity versus pure lysozyme only.
Several nanorod designs aim at cancer detection and
treatment. MicroRNAs (miRNA) are small RNA strands, some
of which can be associated with diseases such as cancer and
diabetes. In the work by Esteban-Fernández de Ávila et al.,33
graphene oxide-covered gold nanowires 200 nm wide were
used to detect miRNA. The ultrasound-propelled nanowires
can penetrate cancer cells where DNA strands bound to the
graphene oxide surface detach and bind to the miRNA. This
causes the graphene oxide–gold nanowires to send out a
fluorescence signal, thereby detecting the presence of a
specific miRNA and thus possibly also a cancer cell.
Moving beyond detecting cancer and towards treating it,
Uygun et al.34 used gold–nickel–gold–polymer nanowires as an
effective anti-cancer agent. These nanowires were propelled by
ultrasound at an average speed of 32 μm s−1 in human serum
and magnetically guided thanks to the nickel. They furthermore
had asparaginase enzymes bound to the polymer segment,
which can deplete cancer cells of the essential amino acid
asparagine and thereby inhibit their growth. A 92% inhibition
of lymphoma cancer cells was observed, compared to only 17%
inhibition for free, non-nanowire-bound asparagine.
While the chemical (e.g. hydrogen decomposition),
magnetic, acoustic (e.g. ultrasound) and biological (e.g.
attaching bacterial flagella) have conventionally been the main
mechanisms of propulsion and navigation for nanorods,35
recent studies have also reported using light for nanorod
propulsion.36 An example is 300 nm wide gold-iron oxide
nanorods, which can be powered by visible light in diluted
hydrogen peroxide, reaching speeds of 33 μm s−1 due to
hydrogen peroxide decomposition at the iron oxide end.37 Due
to the superparamagnetic iron, magnets can be used to steer
the rods in designated trajectories. Similarly, platinum
nanoparticle-coated silicon nanowires in a quinone solution
can achieve propulsion if irradiated with light at the visible or
near-infrared spectrum.38 Speeds of about 5–35 μm s−1 could
then be achieved depending on the power intensity of the light.
Changing the end-surface morphology of the nanowire can
result in different propulsion patterns, from linear to circular.
A final example of light-propelled nanorods is the <210 nm
wide match-like silver–silica nanorod with a silver chloride
tail.39 The nanorods were dispersed in water and irradiated
with UV light, inducing a photocatalytic decomposition of the
silver chloride tail. Depending on the length of the match-like
nanorod, speeds of 4–14 μm s−1 can be achieved.
In addition to these examples of nanorods, often with
intended or even realized medical applications, several other
nanorod designs exist, often being about 200–300 nm wide
and including the elements nickel, gold and/or platinum as
segments.40 However, nanorobots with shapes other than
purely cylindrical but otherwise similar to nanorods have also
been developed. One example is a 700 nm wide and 4000–
4500 nm long V-shaped platinum nanorod.41 It can move in
a hydrogen peroxide medium through the decomposition of
hydrogen peroxide occurring predominantly at the non-
pointy end of the V shape:
H2O2 → H2 + O2
This creates a flow of oxygen, which propels the V-shaped
nanorod forward at speeds of 2–7 μm s−1 depending on the
hydrogen peroxide concertation. The directional movement of
this nanorobot is thus achieved through its V shape, since the
hydrogen peroxide decomposition occurs predominantly at one
end of the robot. However, the nanorobot could only rotate in
micrometer-wide circles and no navigational control was
imposed. Another example of a nanorod consisting not only of
a single cylinder shape is the 200 nm wide and 4800 nm long
nanofish, consisting of several cylindrical segments joined
together: a gold segment as head, two nickel segments as the
body, a gold segment as the caudal fin and three flexible porous
silver hinges linking the other segments (Fig. 1d).42 The
nanofish can be propelled magnetically due to the nickel
segments, swims by waving its tail in a manner similar to actual
fish. The nickel segments in the fish body continuously aligns
themselves with the orientation of the magnetic field, making
the gold segment in the caudal (tail) fin exhibit undulatory
motion, enabling the nanofish to reach a speed of about 31 μm
s−1. A third example of a non-cylindrical-only nanorod type
of nanorobot is a magnetically-controlled two-armed
nanoswimmer consisting of 200 nm wide nickel–gold–nickel
segments with silver hinges in between.43 This nanorobot thus
have two nickel arms doing the swimming and a gold body. In
oscillating magnetic fields, this two-armed swimmer can reach
a speed of about 39 μm s−1 in e.g. seawater. However, the speed
achieved in serum was notably slower – approximately 10 μm


































































































2880 | Environ. Sci.: Nano, 2020, 7, 2875–2886 This journal is © The Royal Society of Chemistry 2020
s−1. To our knowledge, the use of these non-cylindrical-only
nanorods for medical purposes, such as drug delivery, have not
yet been proven by experiments, although several of the authors
express an ambition towards medical applications, arguing for
example that their nanorobot designs and/or propulsion
strategies are feasible in human bodies.
Adopting a structured approach to nanorobot design, Zeng
et al.44 used machine learning to design optimal micro-/
nanorobots for the purpose of catalytic water cleaning,
assuming hydrogen peroxide decomposition propulsion.
Different aspect ratios, shapes, catalytic materials and other
parameters were tested. The results suggested a spherical 398
nm platinum-coated polystyrene nanoparticle, which was then
synthesized and successfully used for decomposing methyl
blue dyes. In addition, two-dimensional (2D) nanoswimmers
were designed by the same group, consisting of 4.6 nm thick
platinum-coated barium ferrite platelets.45 Again, hydrogen
peroxide decomposition was the propulsion mechanism, and
steering was enabled by magnetic control of the iron in the
barium ferrite. The 2D nanoswimmers showed excellent
performance in catalytically removing stains on cloth. These
two non-cylindrical nanorobots are thus clearly intended for
remediation and cleaning rather than for medicine.
Finally, constituting some sort of a hybrid between
nanorods and helices is a nanorobot consisting of a 300–600
nm wide rod with nickel–gold segments and an attached
polypyrrole tail.46 When exposed to acoustic waves, the
polypyrrole tail begins to oscillate and propels the nanorod
forward at speeds up to 60 μm s−1. Although this nanorobot
does not consist of a helical structure, and is thus classified
as a nanorod, the polypyrrole tail acts much like an artificial
flagellum in a similar way as the tails of some helical
nanorobots (see section 2.1).
2.3 DNA nanorobots
DNA nanorobots consist of deoxyribonucleic acid molecules,
thus using DNA as construction material for nano-sized
devices.11,47 Sometimes, they are based on DNA origami,
where DNA molecules are folded to create patterns and
shapes.48 An example of such a nanorobot is the DNA walker
developed by Gu et al.,49 which consists of a trigonal
arrangement of double helices, resembling a symmetrical
three-legged wheel with ‘feet’ that act like ligands. These
DNA ‘feet’ can bind to a larger DNA origami sheet
‘landscape’, across which the DNA walker can ‘walk’ by
rotating 120° and binding to a new bioreceptor in each step.
It can deliver cargo across the DNA sheet landscape to a
designated site, illustrated by the DNA walker delivering
several 5 nm gold nanoparticles in the study. Other structures
able to walk across a DNA origami ‘landscape’ are the
molecular spiders, which consist of protein bodies with three
DNA ‘legs’ and a fourth capture ‘leg’, specifically made by so-
called DNA enzymes.50 Due to the detailed design of the DNA
origami ‘landscape’, the molecular spiders can ‘walk’ across
the landscape as the legs dissociate from one site and
reattach to a new site. Since the spiders have three legs,
complete dissociation is hindered as dissociated legs are held
in place due to the binding of the two other legs and quickly
reattach. The spiders can be made to follow pre-designed
one-dimensional tracks in the ‘landscape’ and even execute
commands like ‘turn’ and ‘stop’. The capture leg is used to
capture the spiders from solution and place them at the
starting position. Although the DNA walkers and molecular
spiders have impressive programmability, it should be noted
that their controlled movement and navigation seems to be
limited to pre-designed DNA ‘landscapes’.
Moving away from such landscapes, DNA nanorobots have
also been used in the in vivo environments of living organism.
An example of such a device is a DNA nanorobot called the I-
switch, which consists of three DNA strands.51 The I-switch can
change shape depending on pH and the two shapes emit light
of different wavelength when the nanorobot is tagged with a
fluorescent molecule. This property can be used for tempo-
spatial mapping of pH changes in living organisms, as shown
for both wild type and mutant nematodes (C. elegans).
Florescence-tagged I-switches were translocated to certain
nematode cells and taken up through receptor-mediated
endocytosis so that pH changes in the cells could be tempo-
spatially mapped. Since many phenomena in cells, including
neurodegeneration and spermatogenesis, are modulated based
on changes in pH in the range where the I-switch is sensitive to
changing shape, there might be several mapping applications
for this DNA nanorobot.
An example of a DNA nanorobot with potential medical
implications is an origami-based hexagonal barrel-shaped
cage-like robot with dimensions of 35 nm × 35 nm × 45 nm
(Fig. 1e).52 The cage can be loaded with various materials,
such as gold nanoparticles and in particular biologically
active payloads, such as antibody fragments. The cage has
‘locks’ that can be ‘unlocked’ by binding to protein receptor
‘keys’. This causes the DNA nanorobot to undergo a drastic
reconfiguration that releases the payloads. The release of
payload was shown in human cells, such as leukaemia cells
and lymphocytes. Similar delivery of therapeutics in vivo was
achieved by tetrahedral DNA nanoparticles.53 The tetrahedral
is made by six self-assembling DNA strands, to which six
strands of a particular type of RNA, called siRNA, were
bound. The siRNA can be used to silence target genes in
tumors. The application was demonstrated by delivering the
tetrahedral-bound siRNA to target tumors in nude mice
through injection in the tail vein. Another similar DNA
nanorobot is the cage-like icosahedral DNA nanocapsule
which can be used to encapsulate biomacromolecules.54 The
nanocapsule can target specific cells and deliver the
molecules to the cytosol.55 The release of the cargo is
controlled by photoirridiation. The application was illustrated
in vivo by delivering a neurosteroid, which can promote
neurogenesis and neuron survival, in the nematode C.
elegans. A final example of a DNA nanorobot is a 90 nm × 50
nm × 2 nm DNA sheet (Fig. 1f) that can fold into a tubular
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and then and fold into a tube, thus encapsulating the cargo.
Furthermore, the nanorobot can be functionalized with DNA
ligands on the outside of the tube, which can bind to a
receptor protein specifically expressed in tumor cells on the
inside of blood vessels and unfold. This way, the tubular
nanorobot was intravenously injected and able to transport
thrombin to target blood vessel tumors in mice, where the
nanorobot unfolded to release its cargo. Since thrombin is a
molecule able to kill cancer cells in blood vessels, this leads
to tumor cell necrosis and tumor growth inhibition.
3. Potential nanorobot hazards
Several of the nanorobot designs described in section 2 offer
the promise of significant health-related benefits, such as
improved cancer therapy. However, considering what can been
learned from previous late lessons with promising technologies
offering great societal benefits, such as the X-rays and
antimicrobials discussed in section 1, risks can outweigh the
benefits for some applications of a technology. So far, only a
few references to environmental and health risks can be found
in the literature about nanorobots. Kostarelos58 wrote briefly
about the safety of nanorobots, commenting that nanorobots
“will need to be toxicologically inert, degradable or expelled
from the body”. One might note that this mainly refers to
human toxicity and not subsequent environmental effects that
might occur after the nanorobots have become expelled from
bodies. Gao and Wang13 wrote about the use of nanorobots
(mainly nanorods) for environmental sensing, monitoring and
remediation. They comment that “the potential toxicity of
micro/nano-scale motors needs to be evaluated to prevent
potential adverse environmental impacts”. However, they do
not provide any specific recommendations on how that could
be accomplished, despite envisioning wide-spread use of
nanorobots in the environment. Surana et al.59 did a study on
DNA nanorobots and their compatibility with the immune
system of higher organisms. They comment that foreign, ‘non-
self’ DNA from other organisms can be harmful and therefore
immunogenic, since they trigger the immune system: “Even
though DNA is a natural biopolymer, when present at the wrong
place at the wrong time it can elicit a strong inflammatory
reaction”. Therefore, they asserted that it is important to
consider the various cellular and systemic responses that such
DNA architectures might elicit, which are likely to be specie-
specific. Such considerations have a dual purpose: it is both to
keep the organism in questions safe from the DNA nanorobot
but also to ensure the proper medical function of the DNA
nanorobot in cells. Again, the focus is on human toxicological
responses rather than on environmental toxicity.
Some consideration of safety can be found in studies
describing DNA nanorobots. The developers of the I-switch
noted that the nematodes injected where “viable and healthy”,
indicating that the I-switch is non-toxic to nematodes given the
applied concentrations.51 In the study by Li et al.56 about the
DNA nanosheet/tubular nanorobot, an assessment of the safety
of the nanorobot was conducted. It was noted that the
nanorobots did not elicit any thrombi or increased blood
coagulation in non-tumor-bearing mice at relevant
concentrations. In addition, no immunological or cytotoxic
responses were shown. They also did not cause any thrombi or
blood coagulation in Bama miniature pigs, which is an animal
similar to humans in anatomy and physiology. Although these
results provide an early indication that such nanorobots might
be safe, they are also limited to human toxicity impacts.
To these considerations of nanorobot risks in the previous
literature, we might add a number of potential hazards. That
foreign DNA can elicit immunologic and inflammatory
responses has been noted above. Other materials used in
contemporary nanorobot designs (see e.g. Table 1) might also
potentially have hazardous properties that warrant further
investigations. For example, the nickel used in order to
magnetically control the propulsion of several helices and
nanorods is known to be allergenic, carcinogenic (though not
in pure metallic form), toxic at high doses and in certain forms,
as well as teratogenic at high doses.60 Allergenic reactions have
already been seen for people working with nano-sized nickel
powder.61 The silver sometimes used for making hinges in
designs with several connected nanorods is also known to be
toxic to organisms in the environment – both in nano-form
and when dissolved into silver ions.62,63 However, silver is not
toxic to humans. High silver intake results in discoloration of
the skin and internal organs (argyria and argyrosis,
respectively), both which do not seem to bring any negative
health effects.62 In addition, the UV light used for propulsion
in some nanorod designs is known to be able to cause skin
damage and, in the worst case, skin cancer.
Foreign DNA, nickel, silver and UV light are all established
hazards. Whether their use in specific nanorobot applications
constitute risks remains to be investigated. Novel hazards
associated with nanorobots might be related to the control of
nanorobot propulsion and navigation – whether by chemical
propulsion, magnetic fields, sound waves, bioreceptor
binding and/or light – potentially making the nanorobots
travel to places in the human body and elsewhere where they
are not supposed to. Should loss of propulsion control or
targeting of an erroneous site occur, hazardous drugs might
be delivered to healthy cells. An erroneous targeting might
cause high concentrations locally, so that a small number of
nanorobots potentially causes much harm.
Besides potential hazards, an additional aspect of risk is
whether organisms will become exposed to the potential
hazard. Whereas nanoparticles have typically been perceived
as extrasomatic risks, released to the environment and
subsequently taken up by organisms,64 the mainly medical
applications envisioned for nanorobots mean that exposure
and uptake to humans might be inherent in the use of
nanorobots rather than unintentional. Environmental
exposure might then potentially occur subsequent to
excretion or discarding of the nanorobots. In addition, the
use of nanorobots for environmental remediation also seems
to imply a direct exposure to organisms in the
environment,13 in that sense being similar to pesticides
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applied to agricultural land. The probability of nanorobot
exposure to relevant organisms might thus be high for these
two promising applications.
4. Regulating nanorobots
As in the early development of X-rays and antimicrobials, there
is currently no regulation targeting the use of nanorobots
specifically. Meeting the current approval requirements for
medical products and devices is arguably one of most lengthy,
thorough and expensive regulatory processes around, with
various phases of clinical testing, safety and benefit
assessment. However, regulations in the EU and elsewhere
have still been criticized for being insufficient when it comes to
more complex drugs.65 It even remains unclear whether
nanorobots are to be consider a medical device or a medicinal
product, for which different sets of regulations apply in the EU
– the Regulation of Medical Devices and Medicinal Products
Directive, respectively. Currently, the ‘mechanism of action’ is
key to decide whether a product should be regulated as one or
the other. These can be pharmacological, immunological or
metabolic means, which is why the categorization of
nanorobots would depend on if they use complex mechanisms
of action combining mechanical, chemical, pharmacological
and immunological properties, as well as if they have both
diagnostic and therapeutic functions.66
One of few regulations that includes specific considerations
for nanomaterials is the EU Regulation on Medical Devices
(Regulation (EU) 2017/745),67 where nanomaterials are defined
according to the European Commission's recommendation: “a
natural, incidental or manufactured material containing
particles in an unbound state or as an aggregate or as an
agglomerate and where, for 50% or more of the particles in the
number size distribution, one or more external dimensions is
in the size range 1–100 nm”.68 This definition, currently under
revision, was clearly developed with nanoparticles in mind
(considering the reference to particle size distribution) and not
with a focus on active nanomaterials. An annex of the Medical
Devises Regulation calls for “special attention” to be given to
nanomaterials without further specification, and again focuses
on nanoparticles: “devices shall be designed and manufactured
in such a way as to reduce as far as possible the risks linked to
the size and the properties of particles which are or can be
released into the patient's or user's body, unless they come into
contact with intact skin only.” If there is a high or medium
potential for internal exposure, devices incorporating or
consisting of nanomaterial should also be classified as ‘Class
III’. This constitutes the highest risk classification in the EU
and is reserved for the most critical devices, for which explicit
prior authorization with regard to conformity with current
standards and rules is required for them to be placed on the
market. However, these rules for classification of medical
devices and conformity assessment procedures were adopted
in 1993 – a decade before the more widespread use of
nanotechnology. Current regulations thus seldom include
nanomaterials, and when they do, the focus is on
nanoparticles. Already more than ten years ago, when
nanorobots were hardly developed, the European Medicines
Agency69 argued that appropriate expertise will need to be
mobilized for the evaluation of the quality, safety, efficacy and
risk management of novel applications of nanotechnology,
such as nanostructures allowing transport across biological
barriers, remote control of nanoprobes, and multifunctional
chemical structures for drug delivery and targeting of disease.
Back then, such novel applications of nanotechnology did not
exist, but current developments of nanorobots are increasingly
making such applications possible.
5. Recommendations
The main applications envisioned for nanorobots are such that
they might potentially become administrated directly to the
human body or the environment (section 3). Such applications
with potential for exposure, akin to those of pharmaceutical
and pesticide applications, warrant consideration into the risks
related to nanorobots. We identified two main potential
hazards related to nanorobots at this early stage: (i) the use of
conventional hazards, such as hazardous materials and UV
light, as well as (ii) the loss of propulsion and navigation
control (section 3). Furthermore, we note a lack of nano-
specific regulation, making it uncertain whether current
regulation will be able to identify and regulate nanorobot
hazards at an early stage of development (section 4). In order
to address this situation, we provide three recommendations
for future research and action. The recommendations are
based on three lessons learned from failing to respond to early
warnings in the past,14 which seem particularly relevant to the
discussion about nanorobot risks: (i) acknowledge and respond
to ignorance, uncertainty and risk in technology appraisal, (ii)
ensure use of ‘lay’ knowledge, as well as specialist expertise,
and (iii) systematically scrutinize claimed benefits and risks.
Following the three recommendations would allow for making
the most of nanorobots while avoiding that their use later turns
out to cause harm to the environment and/or human health.
The first recommendation, based on lessons (i) and (iii), is
to conduct studies of the environmental and human health
risks of different nanorobot designs before they are in
widespread use, moving away from the view that
nanoparticles are the only aspects of nanotechnology for
which risk assessment and regulation are needed. With
nanoparticles, discussions about their risks started early in
the development of nanotechnology. We have since then
learned how important it is that sufficient funding of risk-
related research is provided and that studies are initiated
early on in order to map different risks. Although it is
currently unknown whether nanorobots constitute a potential
risk to human health and the environment, it is possible to
start processes where this can be investigated. At the
moment, risk assessments of medical devices and medicinal
products are largely focused on establishing whether a drug
or device is safe to use under a specific set of conditions
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will probably come as surprises under the current regulatory
framework. It would therefore be wise to conduct broader
studies of the potential risks of nanorobots, considering
different potential hazards and other risk-related aspects.
Table 2 provides a non-exhaustive list of ten questions which
we recommend be addressed in such risk-related studies of
nanorobots, including the consideration of the potential
hazards outlined in section 3. Among these, question 3 about
the future production and use of nanorobots is fundamental.
Currently, nanorobots have only begun to be tested at
laboratory scale for applications such as medicine and
environmental remediation. Their future production and use
will depend on the technical performance of nanorobots in
these applications. In medical applications specifically, an
important prerequisite for successful use is that the
nanorobots can evade the immune systems of the
organisms.70 For DNA nanorobots in particular, this can be
challenging since foreign DNA is immunogenic,59 although
conducted tests for the tetrahedron DNA nanoparticles53 and
nanosheet/tubular DNA nanorobot56 did not indicate any
immunogenic response in mice. Another prerequisite for
future nanorobot use that convenient, large-scale fabrication
methods are achieved. Without a high-enough production
and use of nanorobots, any associated risks will remain low.
However, it should be noted that all technologies are sparsely
used in the earliest beginning of their development, in their
so-called embryonic phase.71 Therefore, an initially low
production and use should not be taken as evidence of future
low production and use. Detailed monitoring of production
volumes, along with technology forecasting and scenario
analyses, are recommended for addressing question 3.
The second recommendation, based on lesson (ii), is that
policy-makers and regulators should reach out to relevant
expert stakeholders and initiate dialogue about how, when
and why nanorobots might be used and address some of the
issues that we know from discussions about nanoparticles
are likely to be contentious for the future of nanorobots.
Such issues include the discussion about nanomaterial and
nanoparticle definitions, which are on-going but have not yet
resulted in consensus.23 Over time, stakeholder positions
seem to have become increasingly entrenched with the
emergence of increasing evidence indicating that
nanoparticles might be associated with harmful effects on
the environment and human health.72 There is no need to
wait with discussions about definitions until early indications
of harm emerges. Discussions about a regulatory relevant
definition of nanorobots should start now when the stakes
are not yet so high for stakeholders involved. The tentative
definition of nanorobots provided in section 1 of this paper
provides a starting point for such discussions.
The third recommendation, also based on lesson (ii), is
the initiation of broader public dialogue about risks and
benefits of nanorobots, as well as how regulatory measures
can be implemented in order to maximize the benefits of
nanorobots while minimizing potential risks. For
nanotechnology in general, there was an early effort already
in 2004 to explore of the general public's attitudes towards
nanotechnologies.73 Many of the identified areas of concern
are still highly relevant for nanotechnologies in general and
nanorobots in particular. For instance, the public raised
questions about the purpose and controllability of
nanotechnologies, whether health and environmental
considerations had been adequately addressed, whether
existing regulation was up to the task, and whether lessons
from the past had been learned. For nanorobots, we
recommend reengaging in a dialogue with the public,
listening to their concerns, and ensuring these concerns are
addressed up-front.
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